Geneos Wealth Management’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,218
Closed -$46K 2581
2025
Q2
$46K Sell
2,218
-2,272
-51% -$42.2K ﹤0.01% 1615
2025
Q1
$79.7K Buy
+4,490
New +$91.6K ﹤0.01% 1688
2023
Q1
Sell
-450
Closed -$7.04K 2048
2022
Q4
$7.04K Buy
+450
New +$7.65K ﹤0.01% 1628

Other funds holding BSTZ

Geneos Wealth Management's BSTZ Position: Q3 2025 in Review

Geneos Wealth Management sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q3 2025, closing a stake of 2,218 shares — an estimated $46K sold.

Geneos Wealth Management first reported a position in BSTZ in Q4 2022 and held it in 3 quarters. The position peaked at $79.7K in Q1 2025. 114 funds tracked by Wall St. Rank hold BSTZ as of Q3 2025.

  • Geneos Wealth Management reported no remaining BlackRock Science and Technology Term Trust position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 2,218 BlackRock Science and Technology Term Trust shares in Q3 2025, an estimated $46K.
  • Geneos Wealth Management first reported a position in BlackRock Science and Technology Term Trust in Q4 2022 and held it in 3 quarters.
  • Geneos Wealth Management's BlackRock Science and Technology Term Trust position peaked at $79.7K in Q1 2025.
  • 114 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.